Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

There is evidence that increased intake of fish oil, rich in long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may beneficially affect the development and course of multiple sclerosis. However, controlled trials have not been able to draw definitive conclusions. The conflicting results could be due to the different mixture of EPA and DHA present in different sources of fish oils used in the clinical trials. In fact, among n-3 polyunsaturated fatty acids, EPA has the most potent effect on myelinogenesis and inflammatory process. The purpose of this chapter is to review the current knowledge on mechanisms underlying these beneficial effects and the evidence of neurological benefits of EPA, looking specifically at multiple sclerosis.

Original languageEnglish
Title of host publicationNutrition and Lifestyle in Neurological Autoimmune Diseases
Subtitle of host publicationMultiple Sclerosis
PublisherElsevier Inc.
Pages267-273
Number of pages7
ISBN (Electronic)9780128054444
ISBN (Print)9780128052983
DOIs
Publication statusPublished - Jan 18 2017

Fingerprint

Eicosapentaenoic Acid
Multiple Sclerosis
Docosahexaenoic Acids
Fish Oils
Omega-3 Fatty Acids
Clinical Trials

Keywords

  • Docosahexaenoic acid
  • Eicosapentaenoic acid
  • Fish oil
  • Multiple sclerosis
  • Myelin repair
  • N-3 Polyunsaturated fatty acids

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Di Biase, A., Attorri, L., Di Benedetto, R., & Salvati, S. (2017). Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment. In Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis (pp. 267-273). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-805298-3.00027-X

Eicosapentaenoic Acid in Myelinogenesis : Prospective in Multiple Sclerosis Treatment. / Di Biase, A.; Attorri, L.; Di Benedetto, R.; Salvati, S.

Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis. Elsevier Inc., 2017. p. 267-273.

Research output: Chapter in Book/Report/Conference proceedingChapter

Di Biase, A, Attorri, L, Di Benedetto, R & Salvati, S 2017, Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment. in Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis. Elsevier Inc., pp. 267-273. https://doi.org/10.1016/B978-0-12-805298-3.00027-X
Di Biase A, Attorri L, Di Benedetto R, Salvati S. Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment. In Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis. Elsevier Inc. 2017. p. 267-273 https://doi.org/10.1016/B978-0-12-805298-3.00027-X
Di Biase, A. ; Attorri, L. ; Di Benedetto, R. ; Salvati, S. / Eicosapentaenoic Acid in Myelinogenesis : Prospective in Multiple Sclerosis Treatment. Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis. Elsevier Inc., 2017. pp. 267-273
@inbook{e1715ae5b29749eeaebfbc4031b7b8f2,
title = "Eicosapentaenoic Acid in Myelinogenesis: Prospective in Multiple Sclerosis Treatment",
abstract = "There is evidence that increased intake of fish oil, rich in long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may beneficially affect the development and course of multiple sclerosis. However, controlled trials have not been able to draw definitive conclusions. The conflicting results could be due to the different mixture of EPA and DHA present in different sources of fish oils used in the clinical trials. In fact, among n-3 polyunsaturated fatty acids, EPA has the most potent effect on myelinogenesis and inflammatory process. The purpose of this chapter is to review the current knowledge on mechanisms underlying these beneficial effects and the evidence of neurological benefits of EPA, looking specifically at multiple sclerosis.",
keywords = "Docosahexaenoic acid, Eicosapentaenoic acid, Fish oil, Multiple sclerosis, Myelin repair, N-3 Polyunsaturated fatty acids",
author = "{Di Biase}, A. and L. Attorri and {Di Benedetto}, R. and S. Salvati",
year = "2017",
month = "1",
day = "18",
doi = "10.1016/B978-0-12-805298-3.00027-X",
language = "English",
isbn = "9780128052983",
pages = "267--273",
booktitle = "Nutrition and Lifestyle in Neurological Autoimmune Diseases",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Eicosapentaenoic Acid in Myelinogenesis

T2 - Prospective in Multiple Sclerosis Treatment

AU - Di Biase, A.

AU - Attorri, L.

AU - Di Benedetto, R.

AU - Salvati, S.

PY - 2017/1/18

Y1 - 2017/1/18

N2 - There is evidence that increased intake of fish oil, rich in long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may beneficially affect the development and course of multiple sclerosis. However, controlled trials have not been able to draw definitive conclusions. The conflicting results could be due to the different mixture of EPA and DHA present in different sources of fish oils used in the clinical trials. In fact, among n-3 polyunsaturated fatty acids, EPA has the most potent effect on myelinogenesis and inflammatory process. The purpose of this chapter is to review the current knowledge on mechanisms underlying these beneficial effects and the evidence of neurological benefits of EPA, looking specifically at multiple sclerosis.

AB - There is evidence that increased intake of fish oil, rich in long-chain n-3 polyunsaturated fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), may beneficially affect the development and course of multiple sclerosis. However, controlled trials have not been able to draw definitive conclusions. The conflicting results could be due to the different mixture of EPA and DHA present in different sources of fish oils used in the clinical trials. In fact, among n-3 polyunsaturated fatty acids, EPA has the most potent effect on myelinogenesis and inflammatory process. The purpose of this chapter is to review the current knowledge on mechanisms underlying these beneficial effects and the evidence of neurological benefits of EPA, looking specifically at multiple sclerosis.

KW - Docosahexaenoic acid

KW - Eicosapentaenoic acid

KW - Fish oil

KW - Multiple sclerosis

KW - Myelin repair

KW - N-3 Polyunsaturated fatty acids

UR - http://www.scopus.com/inward/record.url?scp=85024398486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024398486&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-805298-3.00027-X

DO - 10.1016/B978-0-12-805298-3.00027-X

M3 - Chapter

AN - SCOPUS:85024398486

SN - 9780128052983

SP - 267

EP - 273

BT - Nutrition and Lifestyle in Neurological Autoimmune Diseases

PB - Elsevier Inc.

ER -